ACTIVE

PHARMAN

Export PDF

Financial year 2025 · closed on 30/09/2025

Net result

49,7 k €

-57.1% YoY

Gross margin

97,2 k €

-37.7% YoY

Equity

341,0 k €

+17.1% YoY

What does PHARMAN do?

PHARMAN is a Private limited company incorporated in 1998. Its main activity is: Other professional, scientific and technical activities. Its registered office is in Schoten.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0464.428.377

Incorporation

22/10/1998

Legal form

Private limited company

Registered office

Ganzendreef 1
2900 Schoten · FlandreSee on map

Contributed capital

12 400,00 €

Latest accounts

30/09/2025

Activities (NACE)

74851Other professional, scientific and technical activities· main 82100Office administrative and support activities 82190Photocopying, document preparation and other specialised office support activities 62020Computer consultancy activities 62200Computer programming, consultancy and related activities 64200Activities of holding companies+9

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	97,2 k €	-37.7%	156,1 k €	+208%	50,7 k €	+4.2%	48,7 k €	-43.8%	86,6 k €	+227%	26,5 k €	+167%	-39,3 k €	-131%	128,3 k €	-21.2%	162,8 k €	+19.5%	136,2 k €	-34.8%	208,8 k €	+46.9%	142,1 k €	+3.4%	137,5 k €	+436%	25,6 k €	+149%	-51,8 k €	-543%	-8,1 k €	+52.1%	-16,8 k €	-101%	-8,3 k €	-111%	77,3 k €	-18.5%	94,8 k €
EBITDA	93,6 k €	-37.5%	149,6 k €	+215%	47,5 k €	+6.6%	44,6 k €	-47.7%	85,2 k €	+230%	25,8 k €	+144%	-58,6 k €	-224%	47,4 k €	-46.4%	88,4 k €	+210%	28,5 k €	-67.3%	87,3 k €	+54.7%	56,5 k €	-22.7%	73,0 k €	+11950%	-616,3 €	+98.8%	-52,6 k €	-516%	-8,5 k €	+53.5%	-18,4 k €	+92.6%	-248,0 k €	-438%	73,5 k €	-19.2%	91,0 k €
Operating result	78,4 k €	-42.3%	135,9 k €	+297%	34,3 k €	-10.3%	38,2 k €	-54.0%	83,0 k €	+327%	19,4 k €	+129%	-65,8 k €	-303%	32,4 k €	-60.2%	81,4 k €	+652%	10,8 k €	-81.4%	58,3 k €	+103%	28,8 k €	-38.9%	47,1 k €	+293%	-24,5 k €	+64.5%	-69,0 k €	-551%	-10,6 k €	+42.3%	-18,4 k €	+92.7%	-250,7 k €	-925%	30,4 k €	-18.2%	37,1 k €
Net result	49,7 k €	-57.1%	115,9 k €	+374%	24,5 k €	-23.6%	32,0 k €	-56.2%	73,0 k €	+609%	-14,3 k €	+69.1%	-46,4 k €	-270%	27,3 k €	-62.9%	73,5 k €	+1213%	-6,6 k €	-120%	32,3 k €	+146%	13,1 k €	-62.4%	34,9 k €	+203%	-33,9 k €	+62.6%	-90,7 k €	-773%	-10,4 k €	+37.8%	-16,7 k €	+94.2%	-285,6 k €	-3091%	-8,9 k €	-204%	-2,9 k €
Balance sheet
Equity	341,0 k €	+17.1%	291,3 k €	+30.5%	223,2 k €	+12.3%	198,8 k €	+19.2%	166,8 k €	+77.9%	93,7 k €	-13.3%	108,1 k €	-30.0%	154,4 k €	+21.5%	127,1 k €	+137%	53,6 k €	-11.0%	60,2 k €	+116%	27,9 k €	+89.2%	14,7 k €	+173%	-20,2 k €	-247%	13,7 k €	-86.9%	104,4 k €	-9.0%	114,8 k €	-12.7%	131,5 k €	-68.5%	417,1 k €	-2.1%	426,0 k €
Total assets	682,8 k €	+6.0%	644,1 k €	+10.4%	583,5 k €	-1.0%	589,1 k €	+212%	188,8 k €	+47.0%	128,5 k €	-19.7%	159,9 k €	-74.2%	620,0 k €	+17.7%	526,9 k €	+13.3%	465,1 k €	-12.1%	528,8 k €	-5.5%	559,7 k €	-0.8%	564,4 k €	-12.3%	643,3 k €	+37.5%	467,8 k €	+340%	106,3 k €	-8.1%	115,6 k €	-16.2%	138,0 k €	-88.5%	1,2 M €	-2.8%	1,2 M €
Cash	11,2 k €	-83.0%	66,2 k €	+523%	10,6 k €	-23.5%	13,9 k €	-77.0%	60,5 k €	+32.7%	45,6 k €	-14.9%	53,6 k €	-74.6%	210,5 k €	+26.4%	166,6 k €	+157%	64,7 k €	+16.3%	55,6 k €	-40.5%	93,5 k €	+84.5%	50,7 k €	-24.5%	67,1 k €	+420%	12,9 k €	+159%	5,0 k €	-38.3%	8,1 k €	-87.0%	62,2 k €	+116%	28,8 k €	+576160%	5,0 €
Debts	341,8 k €	-3.1%	352,8 k €	-2.1%	360,2 k €	-7.7%	390,3 k €	+1671%	22,0 k €	-36.5%	34,7 k €	-33.0%	51,8 k €	-88.9%	465,5 k €	+16.5%	399,7 k €	-2.9%	411,5 k €	-12.2%	468,6 k €	-11.9%	531,7 k €	-3.3%	549,6 k €	-6.4%	587,1 k €	+36.0%	431,5 k €	+23240%	1,8 k €	+131%	798,9 €	-87.7%	6,5 k €	-99.2%	780,3 k €	-2.6%	801,3 k €
Other
Workforce	–		–		–		–		–		–		0,3 ETP	-89.3%	2,8 ETP	-9.7%	3,1 ETP	-18.4%	3,8 ETP	+2.7%	3,7 ETP	+5.7%	3,5 ETP	+34.6%	2,6 ETP	+85.7%	1,4 ETP		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 30/09/2025 · 1 active · 3 ended

Active mandates

Marleen Goetschalckx

Mandate

Active

Ended mandates

Guy Wuyts

Manager

Ended

Marleen Goetschalckx

Director

Ended

MARLEEN GOETSCHALCKX

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
ATPHARMA● Active	0465.773.610
GWConsulting● Active	0785.295.073
MGW-SCHOTEN● Active	0825.094.074

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/10/2024	01/10/2023	01/10/2022	01/10/2021	01/10/2020	01/10/2019
Closing of the financial year	30/09/2025	30/09/2024	30/09/2023	30/09/2022	30/09/2021	30/09/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/04/2026	06/05/2025	14/06/2024	26/04/2023	10/03/2022	12/05/2021
General meeting	29/04/2026	30/04/2025	30/04/2024	26/04/2023	07/03/2022	26/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	30/09/2025	29/04/2026	30/04/2026	Dutch	PDF
Micro model	30/09/2024	30/04/2025	06/05/2025	Dutch	PDF
Micro model	30/09/2023	30/04/2024	14/06/2024	Dutch	PDF
Micro model	30/09/2022	26/04/2023	26/04/2023	Dutch	PDF
Micro model	30/09/2021	07/03/2022	10/03/2022	Dutch	PDF
Micro model	30/09/2020	26/04/2021	12/05/2021	Dutch	PDF
Abridged model	30/09/2019	28/04/2020	29/05/2020	Dutch	PDF
Abridged model	30/09/2018	30/04/2019	17/05/2019	Dutch	PDF
Abridged model	30/09/2017	05/03/2018	28/05/2018	Dutch	PDF
Abridged model	30/09/2016	06/03/2017	28/04/2017	Dutch	PDF
Abridged model	30/09/2015	07/03/2016	24/03/2016	Dutch	PDF
Abridged model	30/09/2014	02/04/2015	15/05/2015	Dutch	PDF
Abridged model	30/09/2013	03/03/2014	05/06/2014	Dutch	PDF
Abridged model	30/09/2012	12/06/2013	17/06/2013	Dutch	PDF
Abridged model	30/09/2011	30/05/2012	31/05/2012	Dutch	PDF
Abridged model	30/09/2010	07/03/2011	30/04/2011	Dutch	PDF
Abridged model	30/09/2009	01/03/2010	06/03/2010	Dutch	PDF
Abridged model	30/09/2008	06/07/2009	15/07/2009	Dutch	PDF
Abridged model	30/09/2007	07/04/2008	30/06/2008	Dutch	PDF
Abridged model	30/09/2006	07/05/2007	16/05/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/09/2025 · 1 active · 3 ended

Active mandates

Marleen Goetschalckx

Mandate

Active

Ended mandates

Guy Wuyts

Manager

Ended

Marleen Goetschalckx

Director

Ended

MARLEEN GOETSCHALCKX

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates22/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/01/2012
ONTSLAGEN - BENOEMINGEN
PDF
Mandates02/08/2011
DOEL - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Registered office11/04/2008
MAATSCHAPPELIJKE ZETEL
PDF
Registered office14/11/2006
MAATSCHAPPELIJKE ZETEL
PDF
Registered office15/04/2003
BENAMING - DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202549,7 k €↓
2024
Annual accounts 2024115,9 k €↑
2023
Annual accounts 202324,5 k €↓
2022
Annual accounts 202232,0 k €↓
2021
Annual accounts 202173,0 k €↑
2020
Annual accounts 2020-14,3 k €↑
2019
Annual accounts 2019-46,4 k €↓
2018
Annual accounts 201827,3 k €↓
2017
Annual accounts 201773,5 k €↑
2016
Annual accounts 2016-6,6 k €↓
2015
Annual accounts 201532,3 k €↑
2014
Annual accounts 201413,1 k €↓
2013
Annual accounts 201334,9 k €↑
2012
Annual accounts 2012-33,9 k €↑
2011
Annual accounts 2011-90,7 k €↓
2010
Annual accounts 2010-10,4 k €↑
2009
Annual accounts 2009-16,7 k €↑
2008
Annual accounts 2008-285,6 k €↓
2007
Annual accounts 2007-8,9 k €↓
2006
Annual accounts 2006-2,9 k €
22/10/1998
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMAN

Overview

What does PHARMAN do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline